{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:57:37Z","timestamp":1791925057686,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Research Fund, Oxford"},{"name":"Oxfordshire Health Services Research Committee","award":["1098"],"award-info":[{"award-number":["1098"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR lectureship"],"award-info":[{"award-number":["NIHR lectureship"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCB\/Canadian Rheumatology Association\/ Arthritis Society","award":["Postgraduate rheumatology fellowship award"],"award-info":[{"award-number":["Postgraduate rheumatology fellowship award"]}]},{"DOI":"10.13039\/501100009195","name":"Department of Medicine, Ottawa Hospital","doi-asserted-by":"crossref","award":["Research Fellowship"],"award-info":[{"award-number":["Research Fellowship"]}],"id":[{"id":"10.13039\/501100009195","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)","award":["U54 AR057319"],"award-info":[{"award-number":["U54 AR057319"]}]},{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)","award":["U01AR51874"],"award-info":[{"award-number":["U01AR51874"]}]},{"name":"National Center for Research Resources, US","award":["U54 RR019497"],"award-info":[{"award-number":["U54 RR019497"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00296-017-3855-6","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T03:32:20Z","timestamp":1510198340000},"page":"675-682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7939-5978","authenticated-orcid":false,"given":"Joanna C.","family":"Robson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Cronholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Ashdown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebony","family":"Easley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Kellom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Gebhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Lanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Milman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raashid A.","family":"Luqmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy A.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Tomasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"issue":"1","key":"3855_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3855_CR2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/keq098","volume":"49","author":"N Basu","year":"2010","unstructured":"Basu N, Jones GT, Fluck N, MacDonald AG, Pang D, Dospinescu P et al (2010) Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology (Oxford) 49(7):1383\u20131390","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3855_CR3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF et al (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65(1):270\u2013281","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3855_CR4","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","volume":"48","author":"JH Stone","year":"2003","unstructured":"Stone JH (2003) Limited versus severe Wegener\u2019s granulomatosis: baseline data on patients in the Wegener\u2019s granulomatosis etanercept trial. Arthritis Rheum 48(8):2299\u20132309","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3855_CR5","first-page":"165","volume":"147","author":"F Lhote","year":"1996","unstructured":"Lhote F, Cohen P, Genereau T, Gayraud M, Guillevin L (1996) Microscopic polyangiitis: clinical aspects and treatment. Ann Med Interne (Paris) 147(3):165\u2013177","journal-title":"Ann Med Interne (Paris)"},{"issue":"2","key":"3855_CR6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","volume":"64","author":"M Walsh","year":"2012","unstructured":"Walsh M, Flossmann O, Berden A, Westman K, Hoglund P, Stegeman C et al (2012) Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 64(2):542\u2013548","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3855_CR7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/acr.20471","volume":"63","author":"M Walsh","year":"2011","unstructured":"Walsh M, Mukhtyar C, Mahr A, Herlyn K, Luqmani R, Merkel PA et al (2011) Health related quality of life in patients with newly diagnosed anti-neutrophil cytoplasm antibody associated vasculitis. Arthritis Care Res 63(7):1055\u20131061","journal-title":"Arthritis Care Res"},{"issue":"2","key":"3855_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/acr.20649","volume":"64","author":"G Tomasson","year":"2012","unstructured":"Tomasson G, Boers M, Walsh M, LaValley M, Cuthbertson D, Carette S et al (2012) Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Care Res 64(2):273\u2013279","journal-title":"Arthritis Care Res"},{"issue":"6","key":"3855_CR9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.11471","volume":"49","author":"M Koutantji","year":"2003","unstructured":"Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG (2003) Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 49(6):826\u2013837","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3855_CR10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/acr.20276","volume":"62","author":"K Herlyn","year":"2010","unstructured":"Herlyn K, Hellmich B, Seo P, Merkel PA (2010) Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res 62(11):1639\u20131645","journal-title":"Arthritis Care Res"},{"issue":"12","key":"3855_CR11","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, D\u2019Cruz D, Harper L, Jayne D et al (2014) BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 53(12):2306\u20132309","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3855_CR12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68(3):310\u2013317","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3855_CR13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","volume":"26","author":"M Groh","year":"2015","unstructured":"Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V et al (2015) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) consensus task force recommendations for evaluation and management. Eur J Intern Med 26(7):545\u2013553","journal-title":"Eur J Intern Med"},{"issue":"1","key":"3855_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","volume":"74","author":"J Robson","year":"2015","unstructured":"Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Hoglund P et al (2015) Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis 74(1):177\u2013184","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3855_CR15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"MA Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C et al (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69(6):1036\u20131043","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3855_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/rheumatology\/keu366","volume":"54","author":"J Robson","year":"2015","unstructured":"Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Hoglund P et al (2015) Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials. Rheumatology 54(3):471\u2013481","journal-title":"Rheumatology"},{"issue":"2","key":"3855_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","volume":"20","author":"AK McDonough","year":"2008","unstructured":"McDonough AK, Curtis JR, Saag KG (2008) The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 20(2):131\u2013137","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"3855_CR18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","volume":"157","author":"L Fardet","year":"2007","unstructured":"Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C et al (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient\u2019s opinion. Br J Dermatol 157(1):142\u2013148","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"3855_CR19","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/qhc.0100002","volume":"10","author":"A Bowling","year":"2001","unstructured":"Bowling A, Ebrahim S (2001) Measuring patients\u2019 preferences for treatment and perceptions of risk. Qual Health Care 10(Suppl 1):i2\u2013i8","journal-title":"Qual Health Care"},{"issue":"3","key":"3855_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1369-7625.2004.00281.x","volume":"7","author":"FA Stevenson","year":"2004","unstructured":"Stevenson FA, Cox K, Britten N, Dundar Y (2004) A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 7(3):235\u2013245","journal-title":"Health Expect"},{"issue":"3","key":"3855_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/erp.10.30","volume":"10","author":"C Kerr","year":"2010","unstructured":"Kerr C, Nixon A, Wild D (2010) Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res 10(3):269\u2013281","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"3855_CR22","volume-title":"NVivo qualitative data analysis software Version 10","author":"International Q","year":"2012","unstructured":"International Q (2012) NVivo qualitative data analysis software Version 10. QSR International, Doncaster"},{"issue":"7227","key":"3855_CR23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bmj.320.7227.114","volume":"320","author":"C Pope","year":"2000","unstructured":"Pope C, Ziebland S, Mays N (2000) Qualitative research in health care: analysing qualitative data. BMJ 320(7227):114\u2013116","journal-title":"BMJ"},{"issue":"3","key":"3855_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211\u2013220","journal-title":"N Engl J Med"},{"issue":"3","key":"3855_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221\u2013232","journal-title":"N Engl J Med"},{"issue":"10","key":"3855_CR26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"K Groot de","year":"2009","unstructured":"de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL et al (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150(10):670\u2013680","journal-title":"Ann Intern Med"},{"issue":"6","key":"3855_CR27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2009.114579","volume":"69","author":"MC Goes van der","year":"2010","unstructured":"van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F et al (2010) Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 69(6):1015\u20131021","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3855_CR28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/acr.20176","volume":"62","author":"M Walsh","year":"2010","unstructured":"Walsh M, Merkel PA, Mahr A, Jayne D (2010) Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res (Hoboken) 62(8):1166\u20131173","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"3855_CR29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2215\/CJN.05610611","volume":"7","author":"JG McGregor","year":"2012","unstructured":"McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH (2012) Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol 7(2):240\u2013247","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"3855_CR30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/annrheumdis-2012-202021","volume":"71","author":"WG Dixon","year":"2012","unstructured":"Dixon WG, Bansback N (2012) Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know. Ann Rheum Dis 71(11):1761\u20131764","journal-title":"Ann Rheum Dis"},{"key":"3855_CR31","unstructured":"Mooney J (2015) Research priority setting survey for Vasculitis UK In: Mills J, (ed) Vasculitis UK patient symposium"},{"issue":"1","key":"3855_CR32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/msc.1030","volume":"11","author":"J Mooney","year":"2013","unstructured":"Mooney J, Poland F, Spalding N, Scott DG, Watts RA (2013) In one ear and out the other\u2014it\u2019s a lot to take in: a qualitative study exploring the informational needs of patients with ANCA-associated vasculitis. Musculoskelet Care 11(1):51\u201359","journal-title":"Musculoskelet Care"},{"issue":"10","key":"3855_CR33","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/rheumatology\/keg355","volume":"42","author":"E Morrison","year":"2003","unstructured":"Morrison E, Crosbie D, Capell HA (2003) Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology (Oxford) 42(10):1247\u20131250","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"3855_CR34","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","volume":"72","author":"N Duru","year":"2013","unstructured":"Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F et al (2013) EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 72(12):1905\u20131913","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3855_CR35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R et al (2013) A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 9(1):30","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"3855_CR36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","volume":"42","author":"C Herrmann","year":"1997","unstructured":"Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale\u2013a review of validation data and clinical results. J Psychosom Res 42(1):17\u201341","journal-title":"J Psychosom Res"},{"issue":"9","key":"3855_CR37","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/rheumatology\/ket191","volume":"52","author":"N Basu","year":"2013","unstructured":"Basu N, McClean A, Harper L, Amft EN, Dhaun N, Luqmani RA et al (2013) Explaining fatigue in ANCA-associated vasculitis. Rheumatology 52(9):1680\u20131685","journal-title":"Rheumatology"},{"issue":"2","key":"3855_CR38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/art.24235","volume":"61","author":"DM Carpenter","year":"2009","unstructured":"Carpenter DM, Thorpe CT, Lewis M, Devellis RF, Hogan SL (2009) Health-related quality of life for patients with vasculitis and their spouses. Arthritis Rheum 61(2):259\u2013265","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3855-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3855-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3855-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T03:56:51Z","timestamp":1521086211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3855-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3855"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3855-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]}}}